{"id":"W2104952531","doi":"10.3324/haematol.2014.120220","title":"Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; Institut National Du Cancer","keywords":"Chemoimmunotherapy; Medicine; Vincristine; Dexamethasone; Internal medicine; Blinatumomab; Oncology; Lymphoblastic Leukemia; Refractory (planetary science); Leukemia; Chemotherapy; Chronic lymphocytic leukemia; Cyclophosphamide; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006,0.0006088046,0.001669367,0.0002304289,0.0003585904,0.0008728814,0.0006966724,0.001227206,0.002375528],"category_scores_gemma":[0.001125212,0.0003114238,0.0009188014,0.0004397451,0.0005041994,0.0007579937,0.0002135882,0.002640859,0.0004833394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000923569,"about_ca_system_score_gemma":0.0008286746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008720339,"about_ca_topic_score_gemma":0.002994397,"domain_scores_codex":[0.9996144,0.0001710539,0.00002712602,0.00006378231,0.00003709342,0.00008652853],"domain_scores_gemma":[0.9992115,0.0002626715,0.0001004498,0.00006456563,0.00002992119,0.0003308392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5762693,0.04353004,0.03685455,0.000945267,0.002253634,0.003148052,0.0007235245,0.002417561,0.02449893,0.0006295118,0.008971164,0.2997583],"study_design_scores_gemma":[0.5341989,0.3565616,0.0763372,0.0001446093,0.001544947,0.003106848,0.0002909623,0.001373079,0.003397635,0.0007176168,0.022259,0.0000675851],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908344,0.004573183,0.0001575203,0.001552991,0.0002044633,0.0003599945,0.0004691702,0.00002092181,0.001827339],"genre_scores_gemma":[0.9902604,0.003915795,0.0004403984,0.002019009,0.0003135836,0.0003915218,0.0007304333,0.00001476792,0.001914174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002375528,"threshold_uncertainty_score":0.007946908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02457267889489427,"score_gpt":0.3097826535611139,"score_spread":0.2852099746662196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}